Botulinum type A2 toxin (Shionogi)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameBotulinum type A2 toxin (Shionogi)
Drug Alias NameLMW botulinum type A toxinA2NTXBotulinum type A toxin (150kDa) - Kaketsuken150kDa botulinum type A toxin - KaketsukenLow molecular weight botulinum type A toxin +[6] 
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitorsRho-related GTP-binding protein RhoB inhibitors
TargetsSynaptosomal-associated protein 25Rho-related GTP-binding protein RhoB
Therapy Area/IndicationsMuscle Spasticity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKM Biologics Co LtdTokushima University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTokushima University
Active IndicationsN/A
Inactive IndicationsMuscle Spasticity

Other Information

ATC CodeN/A
Related LinksDrugBank